Genmab(GMAB) - 2022 Q1 - Quarterly Report

Exhibit 99.1 Genmab Announces Financial Results for the First Quarter of 2022 May 11, 2022 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2022 ● Net sales of DARZALEX by Janssen were USD 1,856 million in the first three months of 2022 compared to USD 1,365 million in the first three months of 2021, an increase of USD 491 million, or 36%. ● Royalty revenue was DKK 1,836 million in the first three months of 2022 compared to DKK 1,017 million in the first three months of 2021, an inc ...